 LumiraDx shares these and other findings from its second annual U.S. survey Point of Care Diagnostics: A Clinicians View LumiraDx Point of Care Diagnostics: A Clinicians View US Survey LumiraDx Point of Care Diagnostics: A Clinicians View 2nd Annual US Survey WALTHAM, Mass., Dec. 08, 2022 GLOBE NEWSWIRE LumiraDx Limited Nasdaq: LMDX, a next-generation point ... The post Latest Clinicians U.S. Survey Identifies Point of Care Testing POCT as a Way to Address Healthcare Bandwidth... 